Bee sting case management from emergency to ipd to on discharge

Reading Document
Medical Text Search

bee sting envenomation emergency management anaphylaxis treatment

Medical Text Search

hymenoptera sting inpatient management complications monitoring

GradeResponse
GradeResponse
Medical Text Search

bee sting discharge planning venom immunotherapy follow-up allergist referral

Medical Text Search

massive bee sting toxic envenomation rhabdomyolysis renal failure treatment

I have sufficient sourced content to build a comprehensive answer, supplemented with established clinical knowledge.

Bee Sting Case Management: Emergency → IPD → Discharge


1. TRIAGE & INITIAL ASSESSMENT (Emergency Department)

Classify the Reaction First

CategoryFeaturesUrgency
Local reactionPain, erythema, swelling <10 cm at sting siteRoutine
Large local reaction (LLR)Swelling >10 cm, extending beyond joint, lasting >24 hUrgent
Systemic / AnaphylaxisUrticaria, angioedema, bronchospasm, hypotension, GI symptomsImmediate — life-threatening
Toxic envenomationMultiple stings (>50–100), haemolysis, rhabdomyolysis, coagulopathyResuscitation bay
Serum tryptaseElevated early tryptase confirms mast cell activation / anaphylaxisSend at 1–3 h post-event
Serum tryptase measured early in the reaction provides evidence of anaphylaxis if levels are elevated or significantly increased from basal level (Stinging Insect Hypersensitivity, p. 13).

2. EMERGENCY MANAGEMENT

A. Anaphylaxis Protocol (First Priority)

  1. Remove stinger immediately — scrape, do not squeeze (reduces further venom injection)
  2. Epinephrine (adrenaline) — FIRST-LINE, no contraindications
    • IM epinephrine 0.3–0.5 mg (0.3 mL of 1:1000) into anterolateral thigh
    • Repeat every 5–15 min if no improvement
    • If individual has a bee-sting kit, use subcutaneous epinephrine 0.3 mL of 1:1000, repeated every 20–30 min (Harrison's, p. 13104)
  3. Position: Supine with legs elevated (unless respiratory distress → semi-recumbent)
  4. IV access × 2 + O₂ (high-flow 10–15 L/min via non-rebreather mask)
  5. Fluid resuscitation: IV crystalloid (Normal saline) 1–2 L bolus for hypotension/shock

B. Adjunct Pharmacotherapy

DrugDoseRouteIndication
Epinephrine IV infusion0.1–1 mcg/kg/minIVRefractory shock/anaphylaxis not responding to IM
Salbutamol (nebulised)2.5–5 mgNebuliserBronchospasm
Chlorpheniramine10 mgIM/slow IVH1 antihistamine (adjunct — not first-line)
Ranitidine/Famotidine50 mg / 20 mgIVH2 antihistamine (adjunct)
Hydrocortisone200 mgIVPrevent biphasic reaction (adjunct)
Glucagon1–2 mg IV then infusionIVAnaphylaxis in beta-blocker patients
IV epinephrine and other vasopressors, intubation/supplemental oxygen, fluid resuscitation, bronchodilators, and parenteral antihistamines are the mainstay of profound shock management (Harrison's, p. 13104).

C. Airway Management

  • Early intubation if stridor, voice change, or rapidly progressing angioedema
  • Have surgical airway (cricothyrotomy) kit at bedside

D. Toxic / Massive Envenomation (>50–100 stings)

  • Treat as medical emergency with full resuscitation
  • Anticipate: haemolysis, rhabdomyolysis, AKI, DIC, hepatic injury, cardiac arrhythmias
  • IV hydration: aggressive fluid loading (2–3 mL/kg/h) to maintain UO ≥1 mL/kg/h
  • Urinary alkalinisation (sodium bicarbonate) if myoglobinuria present
  • Monitor ECG continuously

3. MONITORING IN EMERGENCY (Observation Period)

ParameterFrequency
Vitals (BP, HR, SpO₂, RR)Every 15 min × 1 h, then every 30 min × 2 h
Urine outputHourly (catheterise if haemodynamically unstable)
Serum tryptaseAt 1–3 h post-sting (send even if improving)
ECGAt presentation, repeat if abnormal
Minimum observation period: 6 hours for mild-moderate anaphylaxis; 24 hours for severe anaphylaxis, refractory cases, or multiple sting envenomation.
Patients should be observed for 24 h for recurrent anaphylaxis, renal failure, or coagulopathy (Harrison's, p. 13104).

Biphasic Anaphylaxis

  • Occurs in 5–20% of cases, typically 1–8 hours after initial resolution
  • Reason for mandatory observation even after clinical improvement

4. CRITERIA FOR INPATIENT ADMISSION (IPD)

Admit if any of the following:
  • Severe anaphylaxis requiring IV epinephrine or vasopressors
  • Persistent bronchospasm or hypoxia despite treatment
  • Angioedema of airway (actual or threatened)
  • Cardiovascular compromise
  • Multiple stings (toxic envenomation)
  • Renal impairment (↑ creatinine, haematuria, oliguria)
  • Suspected haemolysis or rhabdomyolysis
  • Biphasic reaction
  • Comorbidities: cardiac disease, COPD, elderly, on beta-blockers
  • Inadequate home situation / inability to access emergency care

5. IPD MANAGEMENT

A. Monitoring

InvestigationAt Admission12–24 h48 h
CBCIf abnormal
LFT / RFT
Serum CPK (CK)✓ (if elevated)Track to normalisation
Urinalysis (myoglobin/haemoglobin)If abnormal
Coagulation (PT, aPTT, fibrinogen)✓ if abnormal
ECGRepeat if arrhythmia
Serum tryptase (baseline)Send at 24–48 h for baseline comparison

B. Ongoing Pharmacotherapy

  • Continue IV corticosteroids (methylprednisolone 1–2 mg/kg/day or hydrocortisone 100–200 mg QID) for 24–48 h to suppress biphasic and late-phase reactions
  • Oral antihistamine continuation (cetirizine 10 mg OD or loratadine 10 mg OD)
  • IV fluids — guided by renal function and UO
  • If renal failure develops: nephrology consult, possible haemodialysis
  • DIC: FFP, cryoprecipitate, platelets as indicated

C. Specific Organ Complication Management

ComplicationManagement
AKI / MyoglobinuriaAggressive IV hydration, urinary alkalinisation, avoid nephrotoxins, nephrology consult
RhabdomyolysisIV fluids targeting UO ≥1–2 mL/kg/h, monitor CK daily
HaemolysisMonitor Hb, haematocrit; transfuse if symptomatic anaemia
Hepatic injuryLFT monitoring, avoid hepatotoxic drugs
Coagulopathy / DICFFP, platelets, vitamin K as indicated
ArrhythmiaCardiology consult, continuous telemetry
Serum sickness (7–14 days)Oral prednisolone, antihistamines

6. CRITERIA FOR DISCHARGE

Discharge when:
  • Haemodynamically stable ≥24 h off IV medications
  • Airway clear, no stridor or bronchospasm
  • Tolerating oral intake
  • Renal function normal or improving/stable
  • No active bleeding/coagulopathy
  • Patient educated and has written action plan

7. ON-DISCHARGE MANAGEMENT

A. Prescriptions at Discharge

MedicationDose/DurationPurpose
Oral prednisolone0.5–1 mg/kg/day × 3–5 days (taper)Prevent late-phase / serum sickness
Cetirizine or loratadine10 mg OD × 7 daysAntihistamine cover
Epinephrine auto-injector (EpiPen)0.3 mg × 2 devicesEmergency self-treatment if re-sting
MedicAlert braceletIdentification of allergy in emergencies

B. Patient & Caregiver Education

  1. Avoid bee/wasp habitats — disturbing hives, working in gardens without protection
  2. Wear protective clothing outdoors; avoid floral perfumes
  3. Carry 2 EpiPen auto-injectors at all times
  4. How to use EpiPen — demonstrate and provide written instructions
  5. When to call emergency services — any systemic symptoms after a sting
  6. Stinger removal — scrape with a card, do not squeeze
  7. Recognition of early anaphylaxis signs: urticaria, throat tightness, dizziness, vomiting

C. Follow-Up Plan

TimingAction
24–72 hGP review — wound check, medication tolerance, labs if applicable
2–4 weeksAllergist / Immunologist referral — mandatory after systemic anaphylaxis
At allergistSkin prick test + intradermal testing for Hymenoptera venom
If eligibleCommence Venom Immunotherapy (VIT)

D. Venom Immunotherapy (VIT) — Discharge Counselling

  • VIT is highly effective — reduces risk of systemic reaction on re-sting from ~60% to <5%
  • Indicated after systemic anaphylaxis in adults; consider in children with severe reactions
  • Not typically required for large local reactions alone
  • Consists of subcutaneous venom injections over 3–5 years
  • Referral to allergist at discharge is standard of care

Summary Flow Chart

BEE STING
    │
    ▼
Classify Reaction
    ├── Local only ──► Analgesia, antihistamine, observe 30 min, discharge
    ├── Large local ──► Antihistamine + corticosteroid, observe 4–6 h, discharge with EpiPen
    │
    └── Systemic / Anaphylaxis / Toxic
              │
              ▼
         EMERGENCY
         IM Epinephrine → Fluids → O₂ → Adjuncts → Observe 24 h
              │
              ▼
         ADMIT (IPD) if criteria met
         Monitoring + IV corticosteroids + Organ support
              │
              ▼
         DISCHARGE when stable
         EpiPen × 2 + Prednisolone taper + Antihistamine
         Allergist referral → Venom Immunotherapy

Key References:
  • Harrison's Principles of Internal Medicine, 21st Edition, p. 13104
  • Stinging Insect Hypersensitivity (GLGCA), p. 13
  • WAO/EAACI Anaphylaxis Guidelines; ASCIA Hymenoptera Venom Allergy Guidelines
This is a shared conversation. Sign in to Orris to start your own chat.